stabilised ceretec 0,5 mg kit voor radiofarm. prep. i.v. flac.
ge healthcare bv-srl - exametazime 0,5 mg - kit voor radiofarmaceutisch preparaat - 0,5 mg - exametazime 0.5 mg - technetium (99mtc) exametazime
technescan pyp 20 mg kit voor radiofarm. prep. i.v. flac.
curium belgium s.p.r.l.-b.v.b.a. - natriumpyrofosfaat 20 mg - kit voor radiofarmaceutisch preparaat - 20 mg - natriumpyrofosfaatdecahydraat 20 mg - technetium (99mtc) stannous agent labelled cells
dycoxan 2,5 mg/ml or. susp.
chanelle pharm. man. ltd. - diclazuril 2,5 mg/ml - suspensie voor oraal gebruik - 2,5 mg/ml - diclazuril 2.5 mg/ml - diclazuril - schaap; rund
fendicox, 2,5 mg/ml suspensie voor oraal gebruik voor schapen en runderen
chanelle pharmaceuticals manufacturing ltd. - diclazuril - suspensie voor oraal gebruik - diclazuril 2,5 mg/l, - diclazuril - kalveren; lammeren
fendicox 2,5 mg/ml or. susp.
chanelle pharm. man. ltd. - diclazuril 2,5 mg/ml - suspensie voor oraal gebruik - 2,5 mg/ml - diclazuril 2.5 mg/ml - diclazuril - rund; schaap
givlaari
alnylam netherlands b.v. - givosiran - porfyrie, de lever - verschillende maagdarmkanaal en metabolisme producten - behandeling van acute hepatische porfyrie (ahp) bij volwassenen en adolescenten van 12 jaar en ouder.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische middelen - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - preparaten voor de behandeling van wonden en zweren - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
fendicox 2,5 mg/ml or. susp.
chanelle pharm. man. ltd. - diclazuril 2,5 mg/ml - suspensie voor oraal gebruik - diclazuril
ebglyss
almirall, s.a. - lebrikizumab - dermatitis, atopic - andere dermatologische preparaten - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.